Auna (AUNA) Aktienübersicht
Auna S.A., ein Anbieter von Gesundheitsdienstleistungen, betreibt Krankenhäuser und Kliniken in Mexiko, Peru und Kolumbien. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 1/6 |
| Finanzielle Gesundheit | 2/6 |
| Dividenden | 0/6 |
Belohnungen
Risikoanalyse
AUNA Community Fair Values
Create NarrativeSee what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Auna S.A. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$5.04 |
| 52-Wochen-Hoch | US$6.85 |
| 52-Wochen-Tief | US$4.09 |
| Beta | 0.61 |
| 1 Monat Veränderung | -2.14% |
| 3 Monate Veränderung | -5.08% |
| 1 Jahr Veränderung | -19.62% |
| 3 Jahre Veränderung | n/a |
| 5 Jahre Veränderung | n/a |
| Veränderung seit IPO | -47.50% |
Aktuelle Nachrichten und Updates
Narrative-Update • Jun 29
AUNA: Lowered Price View And 2026 Guidance Will Frame Execution Risks
Analysts have reduced their price target on Auna to $5 from $6, citing lowered estimates following a worse-than-expected Q1 report. What’s in the News for Auna Auna reaffirmed its earnings guidance for 2026, indicating that its full-year outlook for that period remains unchanged.
Narrative-Update • Jun 15
AUNA: Reaffirmed 2026 Guidance Will Challenge Bearish Reset After Q1 Setback
Analysts have trimmed their view on Auna, with the consensus price target moving down by $1 to $5, citing weaker than expected Q1 results and lower company estimates. What's in the News Auna reaffirmed earnings guidance for 2026, maintaining its outlook for the full year.Recent updates
Narrative-Update • Jun 29
AUNA: Lowered Price View And 2026 Guidance Will Frame Execution Risks
Analysts have reduced their price target on Auna to $5 from $6, citing lowered estimates following a worse-than-expected Q1 report. What’s in the News for Auna Auna reaffirmed its earnings guidance for 2026, indicating that its full-year outlook for that period remains unchanged.Narrative-Update • Jun 15
AUNA: Reaffirmed 2026 Guidance Will Challenge Bearish Reset After Q1 Setback
Analysts have trimmed their view on Auna, with the consensus price target moving down by $1 to $5, citing weaker than expected Q1 results and lower company estimates. What's in the News Auna reaffirmed earnings guidance for 2026, maintaining its outlook for the full year.
Narrative-Update • Jun 01
AUNA: Mexico Execution And 2026 Guidance Will Drive Bullish Re Rating
Analysts have reduced their price target on Auna by $1 to $5, reflecting updated assumptions for fair value, discount rate, growth, margins, and future P/E following a worse than expected Q1 report. What's in the News Auna issued new earnings guidance for fiscal year 2026, projecting revenue growth of about 12% on a constant currency basis, within a range of 10% to 14%.Seeking Alpha • May 29
Auna: A Discounted Hospital Operator With An Insurance Twist
Summary Auna trades at depressed valuations despite a stable, integrated insurance and hospital business spanning Peru, Colombia, and Mexico. Operational setbacks in Mexico and Colombia have pressured results, but recent management actions and Q1 trends indicate stabilization and recovery potential. AUNA’s leverage remains high (net debt/EBITDA 3.7x), but recent debt restructuring, improved cash generation, and reduced capex support deleveraging. With a P/FCF of 1.9x and P/E of 5x (2026E), AUNA offers material upside if operational and macro risks continue to abate. Read the full article on Seeking AlphaAnalyseartikel • May 28
Some Investors May Be Willing To Look Past Auna's (NYSE:AUNA) Soft Earnings
Investors were disappointed with the weak earnings posted by Auna S.A. ( NYSE:AUNA ). Despite the soft profit numbers...Narrative-Update • May 04
AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset
Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.Narrative-Update • Apr 19
AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating
Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.Narrative-Update • Apr 05
AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside
Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.Narrative-Update • Mar 22
AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook
Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.Narrative-Update • Mar 08
AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential
Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.Narrative-Update • Feb 22
AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside
Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.Narrative-Update • Feb 07
AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential
Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.Narrative-Update • Jan 24
AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential
Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.Analyseartikel • Jan 23
Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrative-Update • Jan 10
AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks
Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.Narrative-Update • Dec 22
AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential
Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.Narrative-Update • Dec 08
AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential
Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.Narrative-Update • Nov 24
AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential
Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.Analyseartikel • Nov 14
Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Neues Narrative • May 29
High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape
Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.Analyseartikel • Jan 29
A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb
The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...Analyseartikel • Jan 19
Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 15
Auna: Cheap Entry Level In Latin American Healthcare Play
Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking AlphaAktionärsrenditen
| AUNA | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | -1.6% | -0.3% | -1.0% |
| 1Y | -19.6% | 38.5% | 14.7% |
Rendite im Vergleich zur Industrie: AUNA unter dem Niveau der Branche US Healthcare , die im vergangenen Jahr eine Rendite von 38.5% erzielte.
Rendite vs. Markt: AUNA hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 14.7 erzielte.
Preisvolatilität
| AUNA volatility | |
|---|---|
| AUNA Average Weekly Movement | 6.1% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: AUNA hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: AUNADie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1989 | 15,025 | Suso Zamora Leon | www.aunainvestors.com |
Auna S.A., ein Anbieter von Gesundheitsdienstleistungen, betreibt Krankenhäuser und Kliniken in Mexiko, Peru und Kolumbien. Das Unternehmen bietet Prepaid-Krankenversicherungen, Zahn- und Sehversicherungen sowie Onkologiepläne an. Außerdem verkauft es Medikamente.
Auna S.A.'s Grundlagenzusammenfassung
| AUNA grundlegende Statistiken | |
|---|---|
| Marktanteil | US$373.03m |
| Gewinn(TTM) | US$20.19m |
| Umsatz(TTM) | US$1.33b |
18.5x
Kurs-Gewinn-Verhältnis 0.3x
Kurs-Umsatz-VerhältnisIst AUNA zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| AUNA Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | S/4.52b |
| Kosten der Einnahmen | S/2.81b |
| Bruttogewinn | S/1.71b |
| Sonstige Ausgaben | S/1.64b |
| Gewinn | S/68.74m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
Aug 18, 2026
| Gewinn per Aktie (EPS) | 0.93 |
| Bruttomarge | 37.89% |
| Nettogewinnspanne | 1.52% |
| Schulden/Eigenkapital-Verhältnis | 195.0% |
Wie hat sich AUNA auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/26 14:26 |
| Aktienkurs zum Tagesende | 2026/07/24 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Auna S.A. wird von 7 Analysten beobachtet. 6 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Samuel Campos Alves | BTG Pactual |
| Leandro Bastos | Citigroup Inc |
| Raj Sinha | HSBC |